Ophthalmology
Retrospective Cohort Study | Retrospective evaluation of ophthalmological and neurological outcomes for infants born before 24 weeks gestational age.
8 Aug, 2022 | 11:24h | UTC
M-A | GLP1 receptor agonists are associated with increased risk of progression of retinopathy in patients with type 2 diabetes.
2 Aug, 2022 | 12:32h | UTCProgression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis – Journal of Diabetes and its Complications (link to abstract – $ for full-text)
Commentary: GLP1 RA use tied to increased risk of rapidly worsening retinopathy in type 2 diabetes – Medical Dialogues
Guideline | Eyelid surgery for upper visual field improvement.
28 Jul, 2022 | 13:19h | UTCAmerican Society of Plastic Surgeons Evidence-Based Clinical Practice Guideline: Eyelid Surgery for Upper Visual Field Improvement – Plastic and Reconstructive Surgery (free for a limited period)
Guideline | Management of diabetic macular edema.
28 Jul, 2022 | 13:18h | UTC
RCT | Effect of intravitreal Aflibercept vs. Laser Photocoagulation on treatment success of retinopathy of prematurity.
27 Jul, 2022 | 12:01h | UTCEffect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial – JAMA (free for a limited period)
See also: Visual Abstract
Multidisciplinary guidelines for diagnosis and referral in cerebral visual impairment.
25 Jul, 2022 | 12:57h | UTC
AAP Policy Statement | Vision and concussion: symptoms, signs, evaluation, and treatment.
20 Jul, 2022 | 12:14h | UTCVision and Concussion: Symptoms, Signs, Evaluation, and Treatment – Pediatrics
Commentary: Guidance Issued for Managing Visual Disorders After Pediatric Concussion – HealthDay
RCT | Aflibercept monotherapy or bevacizumab first for diabetic macular edema.
18 Jul, 2022 | 11:16h | UTCAflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Some insurance companies mandate a form of step therapy, which involves a trial of an inexpensive drug, bevacizumab, to treat diabetic macular edema. This trial compared two treatments: step therapy and a more expensive drug. #ASRS2022 https://t.co/gOhFTw1C1T pic.twitter.com/8uN9WgmtkD
— NEJM (@NEJM) July 14, 2022
Contemporary management challenges in seropositive neuromyelitis Optica spectrum disorders.
18 Jul, 2022 | 10:59h | UTCContemporary management challenges in seropositive NMOSD – Journal of Neurology
The Global Retinoblastoma Outcome Study | A prospective, cluster-based analysis of 4,064 patients from 149 countries.
14 Jul, 2022 | 12:16h | UTCInvited Commentary: Retinoblastoma as a lens for correctable disparities worldwide – The Lancet Global Health
Retrospective Cohort Study | Magnetic resonance imaging prognostic findings for visual and mortality outcomes in acute invasive fungal rhinosinusitis.
6 Jul, 2022 | 11:16h | UTCM-A: The association between vision impairment and cognitive outcomes in older adults.
30 Jun, 2022 | 10:26h | UTCNews Release: New study indicates sight problems may increase dementia risk in older adults – Taylor & Francis
M-A: Bidirectional association between glaucoma and chronic kidney disease.
30 Jun, 2022 | 10:20h | UTC
Commentary on Twitter
?️NEW Research: Bidirectional association between #glaucoma and chronic kidney disease #CKD
A new meta-analysis suggests a bidirectional relationship between glaucoma and chronic kidney disease, particularly among East Asians
Read more: https://t.co/KzN1wbZz7f pic.twitter.com/CSaFR1x7kE
— eClinicalMedicine – The Lancet Discovery Science (@eClinicalMed) June 16, 2022
Cataract surgery: both eyes on the same day or on different days?
24 Jun, 2022 | 10:55h | UTCCataract surgery: both eyes on the same day or on different days? – Evidently Cochrane
Original Study: Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts – Cochrane Library
Systematic Review: Rituximab for thyroid‐associated ophthalmopathy.
20 Jun, 2022 | 01:16h | UTCRituximab for thyroid‐associated ophthalmopathy – Cochrane Library
Does this patient with acute infectious conjunctivitis have a bacterial infection? The rational clinical examination systematic review.
17 Jun, 2022 | 11:12h | UTCDoes This Patient With Acute Infectious Conjunctivitis Have a Bacterial Infection? The Rational Clinical Examination Systematic Review – JAMA (free for a limited period)
Commentary on Twitter
In this review, bacterial conjunctivitis was more common than viral conjunctivitis in children and viral conjunctivitis was more common than bacterial conjunctivitis in adults, although the prevalence estimates were based on limited evidence. https://t.co/wJ6YXxPRem
— JAMA (@JAMA_current) June 16, 2022
Systematic Review: Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension.
15 Jun, 2022 | 10:30h | UTCRho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension – Cochrane Library
Summary: Rho kinase inhibitors for primary open-angle glaucoma and ocular hypertension – Cochrane Library
Systematic Review: Impact of vision impairment and ocular morbidity and their treatment on depression and anxiety in children.
14 Jun, 2022 | 10:34h | UTCCommentary: Vision Impairment Associated with Greater Depression, Anxiety in Children – HCP Live
RCT: Marine Omega-3 Fatty acid supplementation does not reduce the incidence of dry eye disease in healthy adults.
10 Jun, 2022 | 12:25h | UTCEfficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial – JAMA Ophthalmology (free for a limited period)
Invited Commentary: Another Disappointment for ω-3 Fatty Acid and Dry Eye Disease – JAMA Ophthalmology (free for a limited period)
Commentary on Twitter
In this randomized clinical trial, daily supplementation with marine omega-3 fatty acids (1 gram) for a median of 5.3 years had no significant effect on the incidence of diagnosed #dryeyedisease (DED) or reported DED symptoms. https://t.co/iTBONh6CZK
— JAMAOphthalmology (@JAMAOphth) June 9, 2022
Systematic Review: Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.
8 Jun, 2022 | 10:57h | UTC
Association between retinal layer thickness and cognitive decline in older adults.
1 Jun, 2022 | 11:13h | UTCCommentaries:
Retinal Layer Thickness Linked to Risk of Cognitive Decline – NeurologyToday
Retinal Layer Thickness Linked to Cognitive Decline in Older Adults – HealthDay
Commentary on Twitter
The thickness of macular retinal nerve fiber layers could be a prognostic biomarker of long-term #cognitivedecline in adults ages 60 or older, says @JAMAOphth study. #neurotwitter @AANMember #neurology https://t.co/gKzIEfzimX pic.twitter.com/6uwwS5gmEC
— Neurology Today (@NeurologyToday) May 31, 2022
Systematic Review: Antibiotic prophylaxis for corneal abrasion.
1 Jun, 2022 | 11:06h | UTCAntibiotic prophylaxis for corneal abrasion – Cochrane Library
WHO launches new guide on integrating eye care in health systems.
30 May, 2022 | 11:48h | UTCNews Release: WHO launches new guide on integrating eye care in health systems – World Health Organization
WHO Guidance: Eye care in health systems: guide for action – World Health Organization
Review: Trachoma.
30 May, 2022 | 10:47h | UTCTrachoma – Nature Reviews Disease Primer (if the link is paywalled, try this one)
Infographic: Trachoma – Nature Reviews Disease Primer (if the link is paywalled, try this one)
Commentaries on Twitter
Get Primed on Trachoma with our NEW PrimeView! FREE to download this week! https://t.co/ZfHgLWXfHI pic.twitter.com/aUzsJRSi4J
— Nature Reviews Disease Primers (@DiseasePrimers) May 26, 2022
Our NEW Primer on Trachoma is live today! By @anthonywsolomon @matthewburton70 @EmilyGower6 @ehardingesch @CatieOldenburg @profhughrt and Traoré – @proctorfndn @LSHTM @ICEH_LSHTM @UNCpublichealth. Check it out here: https://t.co/fpIczbGILH
— Nature Reviews Disease Primers (@DiseasePrimers) May 26, 2022
Adverse effects and Safety in Glaucoma Patients – Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD) – A Delphi Consensus Statement.
26 May, 2022 | 10:14h | UTC